This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Guy Tal - Innovator in Immunomodulation
Introduction
Guy Tal is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of immunology, particularly in the development of therapies for inflammatory diseases. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Guy Tal holds a patent for "HSP60, HSP60 peptides and T cell vaccines for immunomodulation." This invention provides novel uses for peptide p277, which consists of positions 437-460 of human heat shock protein 60 (HSP60). The patent outlines methods for modulating immune responses and treating inflammatory diseases. It also details the use of HSP60 and p277 in the treatment or prevention of hepatic disorders. The invention includes methods for treating T cell mediated inflammatory and autoimmune disorders by administering a composition that contains HSP60, p277, and related molecules.
Career Highlights
Guy Tal is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in immunology. His work has garnered attention for its potential to improve treatment options for various immune-related conditions.
Collaborations
Guy has collaborated with notable colleagues, including Meirav Pevsner and Ofer Lider, to further enhance the impact of his research in the field.
Conclusion
Guy Tal's innovative contributions to immunomodulation through his patent demonstrate his commitment to advancing medical science. His work holds promise for improving therapies for inflammatory and autoimmune disorders.